Rare plasma cell disorders, including IgD, IgE, and IgM MM, NSMM, PCL, and HCD, pose substantial diagnostic challenges due to their biological heterogeneity, atypical clinical features, and frequent lack of detectable monoclonal proteins on conventional assays. This evidence concerns the gene CD40LG and heavy chain disease.